Rhinocort Aqua Articles
AstraZeneca and GSK spar on asthma drugs
4 April 2005
Good new data for Altana's Alvesco asthma
28 March 2005
START study confirms Pulmicort tolerability
31 January 2005
Symbicort effective in asthma control
24 January 2005
MAP Pharma completes $30M finance round
20 September 2004
SkyePharma sees net loss fall for 1st-half 2004, as sales rise and R&D costs decrease
20 September 2004
AstraZeneca's 2nd-qtr sales jump 19%
2 August 2004
Stock Commentary - Europe
19 July 2004
AstraZeneca/Skye's new Pulmicort trials
19 July 2004
Cost-effectiveness of COPD combination therapies
7 June 2004
AstraZeneca's 1st-qtr sales pass $5 billion
3 May 2004
AstraZeneca forecasts good growth in Spain
3 May 2004
Benefits of Symbicort single inhaler revealed
29 March 2004
AstraZeneca forecasts sharp rise in earnings but shares slip on mediocre Crestor sales
9 February 2004
Chiesi reports positive results for 2003
2 February 2004
AstraZeneca files Symbicort asthma treatment concept in EU
22 December 2003
Positive new data for adjustable Symbicort
15 September 2003
Symbicort trial data for COPD and asthma
26 May 2003
Symbicort launched for COPD in UK
7 April 2003
FDA backs AstraZeneca steroid in pregnancy
3 February 2003
Chiesi gets German OK for HFA inhaler
20 January 2003
Oxis Turbuhaler OKed for COPD across EU
13 January 2003
AstraZeneca sales rise 6.9% in 2nd quarter
5 August 2002
Italy
15 July 2002
IBD market to double by 2011
13 May 2002
Adolescent use OKed for Symbicort in UK
22 April 2002
AstraZeneca's Symbicort cleared in Canada
18 February 2002
AstraZeneca confident about overcoming loss of Prilosec revenues
11 February 2002
Stock Commentary - Europe
14 January 2002
SkyePharma deal with AstraZeneca
14 January 2002
"Robust" year for AstraZeneca
5 December 2001
Chiesi of Italy sets out expansion plans for rest of Europe
29 November 2001
World asthma therapy markets to 2010
20 November 2001
CML licences budesonide inhaler technology
26 September 2001
Global pulmonary drug delivery market forecasts
24 September 2001
AstraZeneca sales rise 8%, Nexium doing well
26 July 2001
SkyePharma, Meridica unveil new inhaler
5 July 2001
AstraZeneca hit by slip in Losec sales
26 April 2001
AstraZeneca files for Faslodex in USA
30 March 2001
Orion in-house drugs now 28% of turnover
23 February 2001
AstraZeneca issues sales and profits slowdown warning
8 February 2001
Stock Commentary - Europe
11 January 2001
AstraZeneca asthma drug approved in EU
9 January 2001
AstraZeneca's Pulmicort; no change in height with LT therapy
12 October 2000
AstraZeneca launches Pulmicort Respules
10 October 2000
AstraZeneca gains first Symbicort OK
29 August 2000
FDA OKs pediatric asthma drug
10 August 2000
AstraZeneca sees 17% 1st qtr pretax growth
3 May 2000
Hong Kong pharmacy call to ease OTC regs
1 March 2000
AstraZeneca full-year profits up 20% as new products come good
24 February 2000
AstraZeneca launches Rhinocort Aqua in USA
10 February 2000
Recent developments in drug delivery - by Mark Greener
19 January 2000
AstraZeneca files for Symbicort approval
15 December 1999
Flixotide gains first approval for COPD
14 October 1999
Rhinocort Aqua approved in USA
11 October 1999
AstraZeneca's Pulmicort once-daily data
5 August 1999
Ivax launches Paxene in Czech Republic, files PLA
3 August 1999
Positive 1st-qtr news from AstraZeneca
26 May 1999
Astra sees fourth qtr sales leap 46% and rise 27% for full-year 1998
16 February 1999
Swedish pharma market sees 16.2% growth for 1998, says LIF
12 February 1999
Nebulized fluticasone launched in UK
11 February 1999
AstraZeneca's Effect On Rest Of Pharma Sector
17 December 1998
Astra & Zeneca Join In Euro Merger Mania
10 December 1998
Astra & Zeneca Join In Euro Merger Mania
9 December 1998
Astra's Restructuring Hits Profits As Losec Drives Sales
3 November 1998
Atacand In USA
22 October 1998
Minor Boost For Astra With Successor To Losec
12 October 1998
Astra May Invest $124M In French Plant
25 September 1998
Astra And Merck & Co Sign Restructuring Deal
22 June 1998
Strong 1st Qtr Growth In Swedish Pharma Market
15 May 1998
Losec Continues To Drive Astra Sales And Profits
29 April 1998
FDA Advisory Committee Meetings
2 April 1998
Enrollment Starts In Astra's OPTIMA Trial
18 March 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Pulmicort Turbuhaler Reaches US Market
25 February 1998
Astra Remains Popular Stock With Analysts
19 February 1998
Serevent Is Cleared For COPD
12 February 1998
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
